Corcept Therapeutics Inc (CORT)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt CORT? Forum Prognose

Finanzdaten der Corcept Therapeutics Inc-Aktie (CORT)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	6.79% 207.64	194.43	157.21	181.89	182.55
Cost Of Revenue	33.88% 4.596	3.433	2.403	2.956	2.867
Gross Profit	6.31% 203.04	191.00	154.81	178.93	179.68
Operating Expenses	17.34% 192.82	164.32	151.40	153.67	133.08
Benefits Costs and Expenses	18.22% 192.40	162.74	147.60	149.93	129.60
Costs And Expenses	17.68% 197.42	167.75	153.80	156.63	135.95
Operating Income/Loss	61.69% 10.22	26.68	3.416	25.26	46.60
Nonoperating Income/Loss	0.14% 5.024	5.017	6.202	6.698	6.345
Income/Loss From Continuing Operations Before Tax	51.90% 15.24	31.69	9.618	31.96	52.94
Income Tax Expense/Benefit, Deferred	151.31% 9.114	-17.76	-13.71	-3.858	-15.21
Income Tax Expense/Benefit	28.00% -4.425	-3.457	-10.93	1.214	5.73
Income/Loss From Continuing Operations After Tax	44.04% 19.67	35.15	20.55	30.75	47.21
Net Income/Loss	44.04% 19.67	35.15	20.55	30.75	47.21
Preferred Stock Dividends And Other Adjustments	0.309	-	-	0.357	0.523
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.54% 103.55	104.11	104.11	0.138	103.37
Diluted Average Shares	0.87% 119.44	120.48	119.82	1.909	113.72
Basic Earnings Per Share	42.42% 0.19	0.33	0.19	0.29	0.45
Diluted Earnings Per Share	44.83% 0.16	0.29	0.17	0.25	0.41
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	0.309	-	-	0.357	0.523

RPRX

$45.65

0.48%

ROIV

$28.06

1.72%

MRNA

$52.56

1.55%

BNTX

$91.19

1.21%

INSM

$139.50

0.01%

ONC

$284.05

0.44%